Mutations in MAPK pathway genes are present in approximately 85% of LCH cases, with the BRAF V600E mutation occurring in about 50–60% of cases [4, 26, 46, 65–68]. The gene discussed is BRAF; the disease is Langerhans cell histiocytosis.